Treatment-Free Remission in Chronic Myeloid Leukemia

  Abstract:  Tyrosine kinase inhibitors (TKIs) represent a major breakthrough in the treatment of chronic myeloid leukemia (CML). Thanks to these agents, CML has been transformed […]

When Can Tyrosine Kinase Inhibitors Be Discontinued in Patients With Chronic Myeloid Leukemia?

  H&O  What are the treatment goals for patients with chronic myeloid leukemia? FM  With the use of tyrosine kinase inhibitors (TKIs), life expectancy in chronic […]

Counterpoints: Should Treatment for CML Continue Indefinitely?

Since the advent of tyrosine kinase inhibitors (TKIs), chronic myeloid leukemia (CML) has been transformed from a disease that was usually fatal into one in which […]